I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Uveitis: Understanding Eye Inflammation and Retinal Involvement
What Is Uveitis
Uveitis is a broad term for inflammation of the uvea, the middle layer of the eye. It can take several forms depending on where in the eye the inflammation occurs, and it often requires specialized retinal evaluation to diagnose and manage properly.
The uvea includes three connected structures: the iris (the colored ring around the pupil), the ciliary body (which produces the fluid that fills the eye), and the choroid (a layer rich in blood vessels that supplies nutrients to the retina). When any part of this layer becomes inflamed, the condition is called uveitis.
Uveitis is not a single disease but an umbrella term covering many distinct conditions with different causes, patterns of onset, and levels of severity. Some forms are mild and short-lived, while others are chronic and require long-term management to prevent vision loss.
Uveitis is classified based on which part of the eye is inflamed. The type you have guides your treatment plan and helps predict the likely course of your condition.
- Anterior uveitis (also called iritis) affects the front of the eye and is the most common form, accounting for roughly 40 to 70 percent of diagnosed cases.
- Intermediate uveitis affects the vitreous, the clear gel that fills the central portion of the eye.
- Posterior uveitis affects the retina and choroid at the back of the eye and carries the greatest risk to vision.
- Panuveitis involves inflammation across all layers of the uvea simultaneously, from front to back.
Posterior uveitis and panuveitis can directly damage the retina, the light-sensitive tissue responsible for capturing visual information. Inflammation may cause swelling in the macula (the central part of the retina that enables sharp, detailed vision). This swelling is called cystoid macular edema.
Chronic inflammation can also lead to retinal scarring, growth of abnormal blood vessels, and in serious cases, retinal detachment (separation of the retina from the back of the eye). Because the retina has very limited ability to repair itself once meaningfully damaged, early and effective treatment is essential.
Who Can Develop Uveitis
Uveitis can affect people across a wide range of ages and backgrounds. Certain health conditions, genetic traits, and environmental factors can raise the risk of developing this type of eye inflammation.
Uveitis can occur at any age, including in children, but it is most often diagnosed in adults between 20 and 60 years old. It affects both men and women equally. Uveitis is estimated to affect approximately 17 to 52 people per 100,000 in the United States each year, and it is a recognized cause of preventable vision loss, including legal blindness.
Many cases of uveitis are linked to autoimmune diseases, conditions in which the immune system mistakenly attacks the body's own tissues. Conditions commonly associated with uveitis include:
- Ankylosing spondylitis (a form of arthritis that primarily affects the spine)
- Rheumatoid arthritis
- Sarcoidosis (an inflammatory disease that can affect multiple organs)
- Lupus (systemic lupus erythematosus)
- Inflammatory bowel disease, including Crohn's disease and ulcerative colitis
- Multiple sclerosis
Uveitis can also result from infections. Viral infections such as herpes simplex and herpes zoster (shingles) are among the most common infectious triggers. Bacterial causes include tuberculosis and syphilis. Fungal and parasitic infections, such as toxoplasmosis, are also recognized causes.
Eye injuries, certain medications, and prior eye surgeries may trigger uveitis as well. In roughly 30 to 40 percent of cases, no specific cause is identified. This is referred to as idiopathic uveitis.
Certain genetic markers are associated with a higher risk of uveitis. The HLA-B27 gene, for example, is strongly linked to anterior uveitis, particularly in people with ankylosing spondylitis. Smoking may worsen inflammatory eye disease. Stress and illness may also contribute to flare-ups in people who already have a tendency toward uveitis.
Recognizing the Symptoms
Symptoms of uveitis vary depending on which part of the eye is affected and how severe the inflammation is. Some forms develop suddenly, while others progress gradually and quietly over time.
Patients with uveitis often notice one or more of the following symptoms:
- Eye redness
- Eye pain or a dull, persistent aching sensation
- Blurred or hazy vision
- Sensitivity to light, called photophobia
- Floaters, which are dark spots, threads, or shapes drifting through your field of vision
- Decreased visual sharpness
Certain symptoms indicate a potentially serious complication requiring immediate evaluation. Seek care right away if you experience sudden vision loss in one eye, a dramatic and rapid increase in floaters, flashes of light in your vision, or a dark curtain or shadow spreading across your visual field.
These symptoms may signal retinal detachment or severe macular swelling, both of which are urgent and sight-threatening. Even milder symptoms should not be ignored, since uveitis can cause irreversible damage in a short period when left untreated.
Anterior uveitis tends to cause noticeable eye pain, redness, and light sensitivity, often in one eye, and usually develops quickly. Intermediate uveitis more commonly presents with floaters and blurred vision without significant pain or redness. Posterior uveitis often causes gradual vision changes and floaters. Panuveitis can produce a combination of all of these symptoms at once.
Diagnosis and Testing
An accurate diagnosis involves a detailed eye examination and, in most cases, additional imaging studies and laboratory tests. Identifying the type and cause of uveitis is essential for choosing the most effective treatment approach.
A retina specialist will begin by assessing visual acuity (how clearly you see at different distances) and examining the eye using a slit lamp, a specialized microscope with a bright light that allows a detailed view of the eye's internal structures. The specialist looks for inflammatory cells in the front chamber of the eye, within the vitreous, and across the retinal surface.
Dilating the pupils with eye drops gives an unobstructed view of the back of the eye, allowing the specialist to detect swelling, inflammation, scarring, or other signs of retinal involvement.
Advanced imaging helps our team assess how uveitis is affecting the retina and allows us to track changes over time. Our diagnostic tools include:
- Optical coherence tomography (OCT): Produces precise cross-sectional images of the retinal layers, allowing us to detect macular edema and monitor how the retina responds to treatment.
- Fluorescein angiography: A safe imaging dye is injected into a vein in the arm, and photographs capture how it moves through retinal blood vessels, revealing areas of leakage, vessel blockage, or abnormal blood vessel growth.
- OCT angiography (OCTA): Provides detailed imaging of retinal blood flow without requiring a dye injection.
Because uveitis is frequently associated with systemic or infectious disease, blood tests are a standard part of the evaluation. These may include tests for autoimmune markers such as HLA-B27 and antinuclear antibodies (ANA), as well as screening for tuberculosis, syphilis, and other infections.
When a systemic condition is suspected, our retina specialists may coordinate with a rheumatologist (a specialist in autoimmune and inflammatory conditions) or an infectious disease physician to investigate and address the underlying cause.
Specialists use established clinical criteria to grade the level of inflammation inside the eye. This grading evaluates the number of inflammatory cells visible during examination and the degree of haziness within the eye. Grading allows our team to track disease activity over time, evaluate how well treatment is working, and make informed adjustments to your care plan.
Treatment Options
Treatment for uveitis depends on its type, location, cause, and severity. Our retina specialists develop individualized treatment plans with the goal of controlling inflammation, preventing complications, and preserving long-term vision. Treatment decisions are always based on each patient's specific situation.
Corticosteroids are the most common first-line treatment for uveitis. They reduce inflammation quickly and can be delivered in several forms depending on the location and type of uveitis. Options include eye drops, oral pills, periocular injections (injections around the eye), and intravitreal injections (injections directly into the eye).
Sustained-release corticosteroid implants are available for patients who need longer-lasting therapy. The dexamethasone implant (Ozurdex) releases medication into the eye over several months. The fluocinolone acetonide implant (Iluvien) provides an extended course of low-level corticosteroid delivery and is used for chronic uveitis.
When uveitis is chronic, recurrent, or does not respond adequately to corticosteroids alone, immunosuppressive medications may be recommended. These drugs work by calming the overactive immune response that drives inflammation in the eye. Commonly used agents include methotrexate, mycophenolate mofetil, azathioprine, and cyclosporine.
These medications require regular blood monitoring because they can affect liver function, kidney function, and the body's ability to fight infection. Our team closely monitors patients on immunosuppressive therapy and collaborates with other specialists when needed.
Biologic agents target specific proteins within the immune system to reduce inflammation at a molecular level. Adalimumab (Humira) is FDA-approved for the treatment of non-infectious intermediate, posterior, and panuveitis in adults. It is given as a self-administered injection under the skin every two weeks.
Other biologic agents, including infliximab and tocilizumab, may be considered for severe or difficult-to-control uveitis that has not responded to standard immunosuppressive therapy. Biologic treatments have meaningfully improved outcomes for many patients with chronic, sight-threatening uveitis.
When uveitis causes complications such as macular edema or abnormal blood vessel growth in the retina, intravitreal injections of anti-VEGF medications may be added to the treatment plan. Anti-VEGF drugs block a protein called vascular endothelial growth factor, which can drive fluid leakage and abnormal vessel development in the retina. Options a retina specialist may consider include aflibercept (Eylea), ranibizumab (Lucentis), and bevacizumab (Avastin, used off-label for certain eye conditions).
These injections are typically used as part of a broader treatment strategy alongside anti-inflammatory therapy, rather than as a standalone treatment for uveitis.
Surgery may become necessary when uveitis leads to specific complications. A vitrectomy is a procedure in which the vitreous gel inside the eye is carefully removed. This may be done to clear inflammatory debris from the vitreous cavity, repair a retinal detachment, or remove scar tissue affecting the retina. In some cases, vitrectomy also allows the surgeon to obtain a small tissue sample for laboratory analysis when the cause of inflammation remains unclear.
Cataract surgery may eventually be needed, because chronic uveitis and long-term corticosteroid use can cause the eye's natural lens to cloud over. Careful timing and thorough control of inflammation before the procedure are important factors in achieving the best possible surgical outcome.
Living with Uveitis
Uveitis is often a long-term condition. Understanding what to expect, staying actively engaged with your care team, and making supportive lifestyle choices can all play a meaningful role in protecting your vision over time.
The timeline for treatment varies considerably depending on the type of uveitis. Anterior uveitis may resolve within several weeks with appropriate treatment. Intermediate, posterior, and panuveitis often require months or years of ongoing care. Follow-up visits are typically frequent in the early stages, sometimes weekly, to monitor your response to treatment and to make needed adjustments.
As inflammation comes under control, follow-up intervals may lengthen. Patients with chronic uveitis should plan for continued monitoring over the long term. Any sudden change in symptoms between scheduled visits should prompt a call to our office right away.
Without adequate management, uveitis can lead to serious vision-threatening complications. These include:
- Cystoid macular edema (fluid-filled swelling in the central retina)
- Glaucoma (elevated pressure inside the eye that can damage the optic nerve)
- Cataracts (clouding of the eye's natural lens)
- Retinal detachment
- Band keratopathy (calcium deposits forming on the surface of the cornea)
- Permanent vision loss
People living with uveitis can take practical steps to support their eye health and comfort. Wearing quality sunglasses in bright conditions helps reduce discomfort from light sensitivity. A diet rich in fruits, vegetables, and omega-3 fatty acids supports general eye health. Avoiding smoking is particularly important, as smoking is known to worsen inflammatory conditions throughout the body.
While stress does not directly cause uveitis, some patients notice that high-stress periods coincide with flare-ups. Adequate sleep, regular gentle physical activity, and stress management practices may contribute to overall well-being and help support disease management.
Because uveitis is often connected to systemic disease, coordinated care across multiple specialists is frequently necessary. Our retina specialists regularly work alongside rheumatologists, internists, and infectious disease physicians to address both the eye inflammation and any underlying condition that may be contributing to it.
Patients should share a complete medication list with all members of their care team. Some medications used for systemic conditions can affect the eyes, and certain eye treatments can have effects on the rest of the body. Open communication between providers helps ensure safe and coordinated care.
When to Seek Retina Care
Knowing when to contact a retina specialist is essential for protecting your vision, whether you are experiencing symptoms for the first time or managing an existing uveitis diagnosis.
Contact a retina specialist promptly if you notice new or worsening eye pain, increased redness, a sudden rise in floaters, heightened sensitivity to light, or any change in your vision. These may signal the start of a uveitis episode or a flare-up of an existing condition. Early treatment offers the best opportunity to limit damage and preserve your sight.
Seek immediate care if you experience a sudden loss of vision in one eye, a large and rapid increase in floaters, flashes of light, or a dark curtain or shadow spreading across your visual field. These symptoms can indicate retinal detachment or another sight-threatening complication that requires urgent treatment. Do not wait for a routine appointment if any of these symptoms occur.
If you have been diagnosed with an autoimmune disease and develop any eye-related symptoms, ask your doctor for a referral to a retina specialist. While optometrists and general ophthalmologists play an important role in initial screening, the diagnosis and management of posterior uveitis and its retinal complications require the specialized expertise of a fellowship-trained vitreoretinal surgeon.
Patients whose uveitis has been difficult to control with previous treatment may benefit from a specialized evaluation. Our practice has the diagnostic imaging capabilities and clinical depth to assess complex and difficult-to-manage inflammatory eye disease.
Frequently Asked Questions
The following questions address practical concerns that patients with uveitis commonly raise about their care, lifestyle, and what to expect going forward.
Whether uveitis resolves permanently depends on its type and underlying cause. Acute anterior uveitis sometimes clears fully with treatment and does not return. However, many forms of uveitis, particularly posterior uveitis and panuveitis, are chronic or tend to recur, meaning long-term management is needed rather than a single course of treatment. When a systemic cause such as an autoimmune condition is identified and addressed, eye inflammation may also improve. The overall goal of care is to keep inflammation well controlled, reduce complication risk, and preserve as much vision as possible over time.
Uveitis itself cannot be transmitted from person to person. It is not spread through touch, shared items, or close contact. In cases where uveitis is triggered by an underlying infection such as herpes or toxoplasmosis, the infectious agent may have its own transmission routes, but the resulting eye inflammation is not directly contagious. You do not need to worry about passing uveitis to family members or others in your household.
Pink eye, or conjunctivitis, is inflammation of the thin membrane covering the white of the eye and the inner eyelids. It typically causes redness, discharge, and irritation, and is usually caused by a virus or bacteria. Uveitis, by contrast, is inflammation inside the eye within the uveal tract, and it carries a significantly greater risk to vision. While both conditions can cause redness, they are distinct problems requiring very different treatment approaches. If you are uncertain which condition you have, an evaluation by a retina specialist will provide a clear and accurate answer.
Duration varies considerably depending on the type and severity of the episode. Acute anterior uveitis may resolve within several weeks when treated early and consistently. Intermediate, posterior, or panuveitis flares can persist for several months. Chronic uveitis may remain active at a low level for extended periods, even with treatment. Seeking care at the first sign of a flare, rather than waiting to see whether symptoms improve on their own, generally helps shorten its course and reduces the chance of complications. It is also important not to stop prescribed medications without guidance from your retina specialist, even if symptoms appear to have improved.
Every treatment carries some risk, which must be carefully weighed against the serious dangers of uncontrolled inflammation. Long-term corticosteroid use can raise pressure inside the eye (a risk factor for glaucoma), contribute to cataract formation, and in some cases affect blood sugar and bone density. Immunosuppressive medications require regular blood monitoring because they can affect liver and kidney function and reduce the body's defenses against infection. Biologic therapies carry a small increased risk of infection. Our team monitors for side effects throughout treatment and adjusts the plan over time to minimize them while keeping inflammation under control.
For mild anterior uveitis, an optometrist or general ophthalmologist may be able to provide appropriate initial care. However, posterior uveitis, panuveitis, and any case with significant retinal involvement require the diagnostic tools and specialized expertise of a fellowship-trained vitreoretinal surgeon. A retina practice has the advanced imaging capabilities, procedural experience, and clinical depth needed to manage complex uveitis and work to prevent permanent vision loss. If your eye care provider suspects posterior or intermediate uveitis, a referral to a retina specialist is the appropriate next step.
Schedule a Consultation at New England Retina Associates
Uveitis is a serious condition that responds best to early, expert evaluation, and our team at New England Retina Associates is experienced in managing the full spectrum of inflammatory eye disease, including complex cases involving the retina. We welcome patients referred by other providers and those who reach out directly, and we serve patients across Connecticut who are seeking specialized retinal care. If you are experiencing symptoms or have been told you may have uveitis, we encourage you to contact us so we can evaluate your condition and help protect your vision.
30 Years of Care & Commitment
